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Interaction of T-cell antigen receptors with antigen/major 
histocompatibility complex (MHC) molecule complexes on 
antigen-presenting cells (APC) leads to T-cell activation. 
Additional interaction between adhesion molecules on the 
APC and their ligands on T cells is required for optimal 
A ctivation of T lymphocytes is an early and essential event in the complicated processes of the immune sys-tem in response to encountered antigens. By means of a special receptor for antigen binding, the so-called T-cell receptor (TCR), T cells are able to recognize 
small linear peptide fragments of antigen, which are captured in the 
antigen-binding groove of major histocompatibility complex 
(MHC) molecules expressed on the surface of a heterogeneous 
group of cells, c?m~nonly desigt;tated as anti~en-presenting cells 
(APC). Specific bll1dlJ1g of the antlgen/MHC bimolecular complex 
on the APC with the TCR on the T cell induces T-cell activation 
via the transmembrane CD3 molecule, which is associated with the 
TCR. This activation is manifested by the secretion of numerous 
lymphokines, expressi~n of new. T-cell membrane mol~cules.' and 
clonal expansion by antigen-speCific T cells. Although tlllS antlgen-
specific interaction between APC and T cell is thought to be the 
stimulus that initiates activation, it is becoming evident now that 
antigen-indepen?ent i.nteraction between ~P~ and ~ cell is critical 
as well. This antigen-lJ1dependent lJ1teraCtion IS mediated by adhe-
sion molecules, which are pairs of special cell-surface molecules that 
produce intercellular adhesion through receptor-ligand interaction. 
ADHESION MOLECULES 
Cell-surface adhesion molecules dictate the adherent or non-adher-
ent state of cells and are involved not only in cell-cell interactions 
but also in the migration and homing of cells. To date, a large 
number of adhesion molecules and their counter-receptors have 
been identified [1], and this number is still increasing. This article 
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Abbreviations: 
APC: antigen-presenting cell 
cLC: cultured Langerhans cells 
fLC: freshly isolated Langerhans cells 
CD: cluster of differentiation 
HLA: human leukocyte antigen 
ICAM: intercellular adhesion molecule 
LC: Langerhans cell 
LFA: leukocyte function-associated antigen 
MHC: major histocompatibiliry complex 
TCR: T-cell receptor 
T -cell activation. In vitro cultured human epidermal Lan-
gerhans cells (cLC) are powerful APC that express adhesion 
molecules LFA-3 and ICAM-l. Both molecules on cLC serve 
a functional role in the generation of a T-cell response. 
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deals with four of these adhesion molecules and the discussion fo-
cuses on the role they play in the interaction between APC and T 
cells. The four molecules at issue are LFA-l (leukocyte function-
associated antigen 1), CD2 (cluster of differentiation 2), LFA-3, and 
ICAM-l (intercellular adhesion molecule 1). 
LFA-1, which is expressed by most leukocytes, is a transmem-
brane heterodimer consisting of a unique a chain (CDlla) and a 
non-covalently associated common fJ2 chain (CDl8). The single-
chain transmembrane glycoprotein ICAM-l, alternatively termed 
CD54, is (together with the recently discovered ICAM-2) a ligand 
for LFA-l and is expressed on a variety of cell types. CD2, initially 
known as the sheep red blood cell receptor, or LFA-2, is also a 
single-chain transmembrane glycoprotein that is expressed by T 
lymphocytes. Its ligand on the apposing cell is LFA-3 (CD58), a 
molecule with broad tissue distribution. Two isoforms of the sin-
gle-chain LFA-3 molecule exist, differing in their molecular struc-
ture and the length of tails that are anchored into cell membranes. 
The LFA-1/ICAM-l and CD2/LFA-3 adhesive interactions have 
been clearly established by the demonstration that specific binding 
occurs when purified molecules are used and that monoclonal anti-
bodies against the individual molecules can efficiently block recep-
tor-ligand blocking. Based on their molecular sequence, ICAM-1, 
CD2, and LFA-3 are members of the immunoglobulin superfamily, 
whereas LFA-1 belongs to a group of adhesion-promoting proteins 
collectively called the integrins. 
ADHESION MOLECULES AND T-CELL ACTIVATION 
In the generally accepted concept, adhesion-molecule pairs LFA-1/ 
ICAM-1 and CD2/LFA-3 play an essential role during initiation of 
physical contact between APC and T cell [1-3]. This interaction 
helps to overcome the mutual repulsion of APC and T cells and 
establishes an intimate antigen-independent contact, which allows 
an antigen/MHC molecule complex to come into contact with a 
TCR, providing a signal for T-cell activation. Further, it allows 
CD4 or CD8 molecules, present on the cell surface of distinct T-cell 
subsets, to co-recognize the same antigen/MHC molecule com-
plex, thereby stabilizing the binding of the TCR to the antigen/ 
MHC molecule complex and thereby providing an additional acti-
vation signal. CD4 interacts with MHC class II molecules and CD8 
interacts with MHC class I molecules. The significance of adhesion 
molecules in the activation ofT cells by APC is particularly stressed 
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under conditions when the antigen/MHC molecule complex con-
centrations on the membrane of the APC are limited. It has been 
shown that the presence ofICAM-1 as well as LFA-3 is essential for 
successful T-cell stimulation, using MHC class II and/or ICAM-1 
expressing [4] or MHC class II and/or LFA-3 expressing [5] L-cell 
transfectants as APC. 
The duration of binding between APC and T cells and the adhe-
sive potential of these cells depends on many factors, such as the 
number of adhesion molecules expressed and the state of cellular 
activation. Unstimulated naive T cells express moderate levels of 
LFA-1 and CD2, whereas the expression of both ICAM-1 and LFA-
3 is negligible. Following activation, however, the expr~ssion of all 
four molecules is considerably increased. The up-regulauon of these 
adhesion molecules (except ICAM-1) is relatively fixed, because the 
expression remains increased, even after reversion to resting mem-
ory T cells [6]. 
It has to be noted that adhesion molecules do not just simply 
function as "glue" to stick APC and T cells together. These mole-
cules also act as signal transducers, delivering stimulatory signals 
into the cell after binding to their respective ligands. Cross-linking 
of LFA-1 or CD2 molecules on the T cell by monoclonal antibod-
ies, which mimics the binding of ligands, provides additional acti-
vation signals that synergize with the signals induced by triggering 
through the TCR/CD3 complex [5,7]. 
ADHESION MOLECULES ON LANGERHANS CELLS 
Bone marrow·-derived human Langerhans cells (LC) reside pre-
dominantly in the epidermis of normal skin at a suprabasallevel and 
can be identified by the presence of CD1a and the characteristic 
Birbeck granules. LC are a dynamic population that migrates contin-
uously from the skin to the paracortical areas of the skin-draining 
lymph nodes, transporting antigens encountered in the skin and 
presenting them to paracortical T cells. Numerous experiments 
have repetitively revealed that LC have a powerful capacity to acti-
vate T cells and, at present, LC are considered the predominant APC 
of the skin immune system. 
Most current knowledge concerning the expression of membrane 
molecules on human LC (reviewed in [8]) has come from the analy-
sis of LC-enriched epidermal cell suspensions, which are derived 
from skin that has been disrupted with trypsin. These analyses have 
demonstrated that all three types of MHC class II molecules [human 
leukocyte antigen (HLA) HLA-DR, -DP, -DQ] and MHC class I 
molecules are constitutively expressed by human LC [9 -11]. In 
addition, LFA-1, CD2, LFA-3, and ICAM-1 were not present on 
these freshly isolated human LC (fLC), using flow cytofluorometry 
for detection [10,11]. However, because LFA-3 and ICAM-1 are 
trypsin sensitive, their absence in vivo is not certain. Interestingly, 
human LC undergo profound phenotypic alterations during short-
term culture in vitro and, coincidently, their ability to stimulate T 
cells increases considerably [9-12]. With culture, the expression of 
both MHC class I and class II is markedly increased, and both LFA-3 
and ICAM-1 become detectable, whereas LFA-1 and CD2 do not. 
The enhanced functional capacity of cultured LC (cLC) may be 
explained by the increased expression ofMHC products, LFA-3 and 
ICAM-1, and it has been suggested that the reappearance ofLFA-3 
and ICAM-1 on cLC may reflect a recovery from trypsin-exposure 
during cell isolation [10]. 
PARTICIPATION OF LFA-3 AND ICAM-1 ON HUMAN 
LANGERHANS CELLS IN T-CELL ACTIVATION 
In a recent study our object was to define the role of adhesion 
molecules on human LC in the generation of an antigen-specific 
T-cell response. Our approach was to perform inhibition studies 
with monoclonal antibodies that would block receptor-ligand bind-
ing. Purified autologous T cells from peripheral blood were co-cul-
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Figure 1. Diagram of cell-surface molecules on a CD4+ T cell and an 
apposing cultured human epidermal Langerhans cell, interacting during the 
generation of a T-cell response. Ag/MHC II, antigen/MHC class II mole-
cule complex . • , antigen. 
tured with partially enriched LC in the presence of Candida albicans 
antigen. Because human cLC do express LFA-3 and ICAM-1, 
whereas fLC do not, the former were included. Figure 1 is a schema-
tic representation of the membrane molecules that are presumably 
involved in the interaction between cLC and T cells during the 
induction of T-cell proliferation. We observed that the antigen-
specific T-cell response induced by cLC was suppressed in a dose-
dependent fashion when graded concentrations of anti- LFA-3 or 
anti - ICAM-1 antibodies were continuously present in the co-cul-
tures. Simultaneous addition of both antibodies resulted in an even 
more 'pronounced reduction ofT-ceil proliferation. Irrelevant con-
trol antibodies of the same isotype as anti-LFA-3 or anti- ICAM-1 
had no inhibitory effects, excluding non-specific suppressive effects 
of antibodies on T-cell activation. The results of our antibody-me-
diated inhibition experiments were in complete agreement with 
other reports concerning the role of adhesion molecules on human 
tonsillar dendritic cells [13] and on human peripheral blood mono-
cytes [14] . 
Our second approach to assess the significance of LFA-3 and 
ICAM-1 on cLC, was to eliminate trypsin-susceptible molecules 
from the cell surface of cLC by a brief exposure to trypsin prior to 
co-culture with T cells. Pre-treatment of cLC with this enzyme 
resulted in a considerable reduction of their stimulatory capacity, 
without reducing cell viability. Remarkably, when fLC (already 
devoid ofLFA-3 and ICAM-1) were treated with trypsin, no reduc-
tion of function occurred. A drawback of the enzyme treatment is 
the possibility that re-expression ofLFA-3 and ICAM-1 may take 
place during the course of the T-cell proliferation assay. In addition, 
other (yet unknown) trypsin-susceptible membrane structures in-
volved in T -cell activation may also be affected. 
In conclusion, the prevention of interaction between either LFA-
3 or ICAM-1 on cLC and their respective ligands on the T cells leads 
to a considerable reduction in proliferation, suggesting that both 
adhesion molecules play an important functional role in antigen-
specific T-cell activation. As outlined above, this role can be ex-
plained as follows: LFA-3 and ICAM-1 may permit facilitation 
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of the physical cont~ct betwe~n cLC and T cells and may deliver 
additional signals via theLr lIgands CD2 and LFA-l on the T 
cell. 
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